The RECoVaM Study Group | Twitter | Linktree

RECoVaM was initiated during the COVID-19 pandemic to provide timely evidence needed to guide vaccination policies. The project evaluated vaccine effectiveness under the National COVID-19 Immunisation Programme (PICK), for different vaccine types, subgroups, and periods dominated by various SARS-CoV-2 variants. It also strengthened the integration and analysis of data across multiple national health databases. Access to near real-time information on cases, vaccinations, and mortality informed vaccination strategy decisions and supported efforts to build public confidence and increase vaccine uptake

About us

Parliamentary statements

14th Parliament

Parliament video

Video abstract and Press conference

Video 1

Video 2

Video 3

Peer-reviewed publications

Manuscript 1 

Manuscript 2

Manuscript 3

Manuscript 4

Manuscript 5

Manuscript 6

Manuscript 7

Manuscript 8

Manuscript 9

Manuscript 10

News articles and media coverage

From the desk of DG

CodeBlue

The EDGE Malaysia

Infographics

CME- NIH